The post operative analgesic effects of dexamethasone versus ondansetron as adjuvant to 0.25% bupivacaine bupivacaine via intraperitoneal infiltration in patients undergoing elective laparoscopic cholecystectomy
Phase 3
- Conditions
- Health Condition 1: K800- Calculus of gallbladder with acutecholecystitisHealth Condition 2: O- Medical and Surgical
- Registration Number
- CTRI/2023/05/052968
- Lead Sponsor
- JSS HOSPITA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
ASA I-II
Surgery duration up to or less than 2 hours
Exclusion Criteria
Patient using Steroids or NSAIDS
Patients with IHD/ Rhythm abnormalities.
Patients with significant hepatic, renal or hematological disorders.
Patients allergic to study drugs
Patients and his/her legally accepted representatives not willing to provide their voluntary written informed consent for participation in the study.
Surgery lasting for more than 2 hours
If the surgery gets converted to open cholecystectomy
Pregnant patients
Any patient with postoperative drain
Patients with BMI > 30
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Significant reduction in post operative pain in patients who have received 8mg dexamethasone than 4mg ondansetron via intraperitoneal infiltrationTimepoint: IN A TIME PERIOD OF 24 HOURS POST SURGERY
- Secondary Outcome Measures
Name Time Method Reduction in postoperative nausea and vomitingTimepoint: 24 hours